If this is your company, CONTACT US to activate Packbase™ software to build your portal.

Webpackaging logo

AR Packaging elevates its leading position in healthcare packaging by acquiring Kroha GmbH

  • AR Packaging
Europe, Germany, Austria, Germany, Health, Pharmaceuticals

The growth of AR Packaging continues with the acquisition of German based Kroha GmbH, a specialist in folding carton packaging for pharmaceuticals. This strategic move further strengthens the Group’s leading position and capabilities to service both mid-sized and large customers in the pharmaceutical industry.

AR Packaging’s strategic direction for growth in the healthcare sector started with the acquisitions of the former K+D AG, rlc packaging Group and BSC Drukarnia in 2019 and early 2020. The acquisition of Kroha is the next step in line with this strategy and will be another highly attractive addition to the Group’s offering of healthcare packaging.

“I am very pleased to see AR Packaging as the chosen partner for Kroha. The owner Franz Kroha has developed the company to a well recognised supplier to healthcare customers with high demands”, said Harald Schulz, President and CEO of AR Packaging. “Taking over the responsibilities of Kroha confirms our ambition for further growth of the AR Packaging core segments, both organically and through further acquisitions.”

Kroha GmbH is a family owned company producing folding cartons and leaflets at its factories in Miesbach and Barleben, Germany. With its sole focus on pharmaceutical packaging, 250 highly skilled employees and a strong management team uphold high quality assurance and efficient operations.

“AR Packaging has a clear strategic focus on healthcare packaging which fits very well with the ambitions of Kroha”, said Franz Kroha, the current owner of Kroha GmbH. “I am convinced that my company will have the best opportunities for further development with AR Packaging’s extensive expertise and strong commitment to quality, speed and customer focus.”

Completion of the acquisition is subject to regulatory approvals and is expected before the end of 2020.

See also

  • Company News
  • English
  • Modified 02 Nov 2020
  • Hits 654